John F. Tomayko

John brings with him 30+ years of experience in clinical infectious diseases. Previously, he held senior roles in GSK (Senior Director, Clinical Development Infectious diseases), Spero (CMO), Pfizer (Global Clinical Lead, Anti-infectives), and is currently the VP, Clinical Development at F2G.